Nielsen E B, Ginn S R, Cunningham K A, Appel J B
Behav Brain Res. 1985 Aug;16(2-3):171-6. doi: 10.1016/0166-4328(85)90090-7.
In two groups of rats trained to discriminate 0.08 or 0.16 mg/kg of lysergic acid diethylamide (LSD) from saline, pirenperone and ketanserin completely blocked the stimulus effect of LSD. Pizotifen (BC-105) blocked the LSD cue when the training dose was 0.08 mg/kg, but had variable effects in the 0.16 mg/kg of LSD-trained group. The antagonism of the 0.08 mg/kg cue occurred at doses of the antagonists which blocked [3H]spiroperidol labeled 5-HT2 receptors in the frontal cortex in vivo; binding in the striatum was unaffected by the LSD antagonists. However, in doses which produce the LSD cue, neither LSD nor the 5-HT agonist, 5-methoxy-N,N-dimethyltryptamine, which substitutes for LSD, inhibited the binding in either the cortex or the striatum. The results are discussed in relation to the possible neuropharmacological basis for the LSD cue.
在两组经过训练以区分0.08或0.16毫克/千克麦角酸二乙酰胺(LSD)与生理盐水的大鼠中,哌仑西平和酮色林完全阻断了LSD的刺激效应。当训练剂量为0.08毫克/千克时,苯噻啶(BC - 105)阻断了LSD提示,但在0.16毫克/千克LSD训练组中产生了不同的效果。0.08毫克/千克提示的拮抗作用发生在体内能阻断额叶皮质中[3H]螺哌啶醇标记的5 - HT2受体的拮抗剂剂量时;纹状体中的结合不受LSD拮抗剂的影响。然而,在产生LSD提示的剂量下,LSD和替代LSD的5 - 甲氧基 - N,N - 二甲基色胺这两种5 - HT激动剂均未抑制皮质或纹状体中的结合。本文结合LSD提示可能的神经药理学基础对结果进行了讨论。